Pfizer launches new medication for migraine treatment

17 Nov 2025 Evaluate

Pfizer has launched a new medication for migraine treatment. The company has introduced Rimegepant ODT in India for adults with a previous insufficient response to triptan, the usual drugs for treating migraine.

The new medication delivers rapid and sustained pain relief lasting up to 48 hours post-treatment, while not associated with the risk of medication overuse headaches. Rimegepant will be available in a 75 mg orally disintegrating tablet (ODT) form, designed for convenient administration without the need for water.

Pfizer is engaged in manufacturing, marketing, trading and export of pharmaceutical products.

Pfizer Share Price

4991.05 -11.75 (-0.23%)
05-Dec-2025 12:26 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.90
Dr. Reddys Lab 1280.20
Cipla 1521.35
Zydus Lifesciences 933.70
Lupin 2100.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×